Alzheimer's Disease News and Research

RSS

Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.

Cognoptix provides update on multi-site clinical trial of SAPPHIRE II eye test

Cognoptix announced today that it has reached the halfway point in a multi-site clinical trial of its SAPPHIRE II eye test designed to identify Alzheimer's disease patients via a beta amyloid ("Ab") signature in their eyes.

10 Apr 2013

Weill Cornell Medical College sets up new Feil Family Brain and Mind Research Institute

Weill Cornell Medical College has established the new Feil Family Brain and Mind Research Institute, a unique, multidisciplinary translational neuroscience research hub. Named in honor of long-time benefactors Gertrude and Louis Feil, the institute was created with a generous $28 million gift from the Feil Family.

9 Apr 2013

Roche, Isis Pharmaceuticals to develop neurodegenerative therapeutics for Huntington's disease

Roche and Isis Pharmaceuticals, Inc today announced that they have formed an alliance to develop treatments for Huntington's disease based on Isis' antisense oligonucleotide technology.

9 Apr 2013

Scientist receives NIH grant to study genetic causes of autism spectrum disorders in African Americans

The National Institutes of Health has awarded Dr. Daniel Geschwind, director of the UCLA Center for Autism Research and Treatment, a five-year, $10 million grant to continue his research on the genetic causes of autism spectrum disorders and to expand his investigations to include the genetics of autism in African Americans.

9 Apr 2013

Study examines relationship between elder abuse, health services utilization

Older adults who are subject to elder abuse, neglect and exploitation face a greater risk of being hospitalized than other seniors, according to the results of a study published in the April 8 issue of JAMA Internal Medicine.

9 Apr 2013

MentisCura launches clinical center for early detection of Alzheimer's disease, dementia

MentisCura Diagnostics today announced the launch of its first clinical center for the early detection of Alzheimer's disease and other dementias.

8 Apr 2013

Research shows new separation process could help advance stem cell therapies

A new separation process that depends on an easily-distinguished physical difference in adhesive forces among cells could help expand production of stem cells generated through cell reprogramming.

8 Apr 2013

Patent covering methods of treating ALS receives notice of allowance

Neuralstem, Inc. announced today that it received a notice of allowance for patent application 12/404,841. This patent covers methods for treating amyotrophic lateral sclerosis (ALS or Lou Gehrig 's disease) with expanded spinal cord stem cells, including NSI-566.

6 Apr 2013

Study applying OPKO Health's technology to identify synthetic peptoid in NMO patient serum published

OPKO Health, Inc. today announced the publication of a study applying its novel library screening technology to identify a synthetic peptoid that binds to anti-Aquaporin 4 antibodies in the serum of patients with Neuromyelitis optica.

6 Apr 2013

Studies, search for genetic risk factors needed to predict individual's risk for traumatic brain injury

One of the most controversial topics in neurology today is the prevalence of serious permanent brain damage after traumatic brain injury. Long-term studies and a search for genetic risk factors are required in order to predict an individual's risk for serious permanent brain damage, according to a review article published by Sam Gandy, MD, PhD, from the Icahn School of Medicine at Mount Sinai in a special issue of Nature Reviews Neurology dedicated to TBI.

6 Apr 2013

New technology provides clear images of brain with Parkinson's without use of intrusive restraints

A technology being developed at Oak Ridge National Laboratory promises to provide clear images of the brains of children, the elderly and people with Parkinson's and other diseases without the use of uncomfortable or intrusive restraints.

5 Apr 2013

Dementia care costs top other diseases in US, study finds

The costs of caring for people with dementia in the U.S. are comparable to - if not greater than - those for heart disease and cancer, according to new estimates by researchers at the University of Michigan Health System and nonprofit RAND Corporation.

5 Apr 2013

Researchers identify new set of genetic markers for Alzheimer's

Researchers at Washington University School of Medicine in St. Louis have identified a new set of genetic markers for Alzheimer's that point to a second pathway through which the disease develops.

5 Apr 2013

TSRI scientists identify new drugs for human prion disease

Human diseases caused by misfolded proteins known as prions are some of most rare yet terrifying on the planet—incurable with disturbing symptoms that include dementia, personality shifts, hallucinations and coordination problems.

4 Apr 2013

Researchers use brain-imaging tool and stroke risk assessment to detect signs of cognitive decline

UCLA researchers have used a brain-imaging tool and stroke risk assessment to identify signs of cognitive decline early on in individuals who don't yet show symptoms of dementia.

4 Apr 2013

Obama rolls out $100M initiative to study the brain

President Obama revealed a $100 million plan Tuesday to study and better understand the human brain in part to attempt to find better treatments for Alzheimer's and other diseases.

4 Apr 2013

First Edition: April 3, 2013

Today's headlines include reports about how the latest round of payment rates for private Medicare plans led to stock market gains for insurers.

3 Apr 2013

Research facilitates development of treatments, cures to Alzheimer's disease

A team of researchers at The New York Stem Cell Foundation Research Institute led by Scott Noggle, PhD, Director of the NYSCF Laboratory and the NYSCF - Charles Evans Senior Research Fellow for Alzheimer's Disease, and Michael W. Nestor, PhD, a NYSCF Postdoctoral Research Fellow, has developed a technique to produce three-dimensional cultures of induced pluripotent stem cells called embryoid bodies, amenable to live cell imaging and to electrical activity measurement.

3 Apr 2013

Risk prediction tools that estimate future risk of stroke and heart disease may also predict memory loss

Risk prediction tools that estimate future risk of heart disease and stroke may be more useful predictors of future decline in cognitive abilities, or memory and thinking, than a dementia risk score, according to a new study published in the April 2, 2013, print issue of Neurology®, the medical journal of the American Academy of Neurology.

2 Apr 2013

MIT scientists model structure of alpha synuclein protein associated with Parkinson's

Clumps of proteins that accumulate in brain cells are a hallmark of neurological diseases such as dementia, Parkinson's disease and Alzheimer's disease. Over the past several years, there has been much controversy over the structure of one of those proteins, known as alpha synuclein.

2 Apr 2013

Alzheimer's Disease News and Research

Further Reading

Cognoptix provides update on multi-site clinical trial of SAPPHIRE II eye test

Weill Cornell Medical College sets up new Feil Family Brain and Mind Research Institute

Roche, Isis Pharmaceuticals to develop neurodegenerative therapeutics for Huntington's disease

Scientist receives NIH grant to study genetic causes of autism spectrum disorders in African Americans

Study examines relationship between elder abuse, health services utilization

MentisCura launches clinical center for early detection of Alzheimer's disease, dementia

Research shows new separation process could help advance stem cell therapies

Patent covering methods of treating ALS receives notice of allowance

Study applying OPKO Health's technology to identify synthetic peptoid in NMO patient serum published

Studies, search for genetic risk factors needed to predict individual's risk for traumatic brain injury

New technology provides clear images of brain with Parkinson's without use of intrusive restraints

Dementia care costs top other diseases in US, study finds

Researchers identify new set of genetic markers for Alzheimer's

TSRI scientists identify new drugs for human prion disease

Researchers use brain-imaging tool and stroke risk assessment to detect signs of cognitive decline

Obama rolls out $100M initiative to study the brain

First Edition: April 3, 2013

Research facilitates development of treatments, cures to Alzheimer's disease

Risk prediction tools that estimate future risk of stroke and heart disease may also predict memory loss

MIT scientists model structure of alpha synuclein protein associated with Parkinson's

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News